TrialJournal of endocrinological investigation2013

Supplementation with L-arginine favorably influences plasminogen activator inhibitor type 1 concentration in obese patients. A randomized, double blind trial.

P Bogdanski et al.PubMed ↗Publisher ↗

No numbers read from the abstract.